右美托咪定对小儿扁桃体切除术围手术期并发症的疗效:一项Meta分析
该Meta分析纳入15项随机对照研究共1552例儿童,评估围手术期右美托咪定作为扁桃体切除术辅助用药对比阿片类药物或安慰剂的效果。结果显示右美托咪定可显著降低术后疼痛评分、PACU镇痛药需求、躁动发生率和程度以及血氧饱和度下降发生率,且不延长PACU停留时间。
要点
- 右美托咪定可减轻小儿扁桃体切除术后疼痛和躁动
- 右美托咪定降低PACU镇痛药需求和血氧饱和度下降发生率
- 给药方式不影响右美托咪定的有效性
核心结论
- 围手术期使用右美托咪定可为接受腺扁桃体切除术的儿童提供疼痛和躁动缓解且无副作用。
- 鉴于部分参数结果异质性高,需进一步开展方法学严谨的临床试验证实。
研究设计与样本
- 系统评价与Meta分析,检索5个数据库从建库至2017年4月。
- 纳入15项前瞻性随机对照研究,共1552例儿童。
- 干预组为扁桃体切除术加右美托咪定,对照组为安慰剂或阿片类药物。
主要发现
- 右美托咪定组术后疼痛评分和PACU镇痛药需求显著低于对照组。
- 右美托咪定组PACU躁动发生率和程度及血氧饱和度下降发生率显著低于对照组。
- 两组PACU停留时间无显著差异。
- 按给药方式(单次注射或持续输注)亚组分析,右美托咪定均有效减少术后并发症。
临床怎么用
- 可考虑围手术期使用右美托咪定作为小儿扁桃体切除术的辅助用药以减轻疼痛和躁动。
- 给药方式可根据临床情况选择单次注射或持续输注。
局限性
- 部分参数结果异质性高。
- 需进一步开展方法学严谨的临床试验确认结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to assess the effects of perioperative dexmedetomidine as an adjuvant to tonsillectomy compared with opioid or sham in children. DATA SOURCE: Five databases (PubMed, SCOPUS, Embase, Web of Science, and Cochrane Central Register of Controlled Trials) were searched from inception of article collections to April 2017. REVIEW METHODS: Prospective, randomized controlled studies that compared outcomes between children who underwent tonsillectomy plus dexmedetomidine administration (intervention) and children who underwent tonsillectomy with placebo or opioid (control) were systemically and independently reviewed by two researchers. The outcomes of interest were emergence agitation, postoperative pain intensity, rescue analgesic consumption, and other morbidities (nausea and vomiting and agitation). RESULTS: Fifteen studies with n = 1,552 met the inclusion criteria. Postoperative pain scores and the need for analgesics in the postanesthesia care unit (PACU) were significantly decreased in the dexmedetomidine group versus the control group. The incidence and degree of agitation and desaturation incidence in the PACU also were significantly lower in the dexmedetomidine group than in the control group. Additionally, there was no significant difference in the duration of staying PACU between both groups. In subgroup analyses by administration method (bolus injection or continuous injection), dexmedetomidine was shown to be effective at reducing postoperative morbidities regardless of administration method. CONCLUSION: Perioperative administration of dexmedetomidine can provide pain and agitation relief without side effects in children undergoing adenotonsillectomy. Considering the high heterogeneity of results within some parameters; however, further clinical trials with robust research methodology should be conducted to confirm the results of this study. Laryngoscope, 128:E184-E193, 2018.
引用
- Cho HK, Yoon HY, Jin HJ, et al. Efficacy of dexmedetomidine for perioperative morbidities in pediatric tonsillectomy: A metaanalysis. Laryngoscope. 2017. PMID: 28895149. doi:10.1002/lary.26888
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。